Metraipolis › archive › dc_867fce42446e

The Emerging Role of Glucagon-like Peptide 1 (GLP-1)-Based Medications in the Treatment of Heart Failure, with a Focus on Heart Failure with Preserved or… — Europe PMC PMID:42195123

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42195123
DOI
10.3390/medicina62050870
License (as archived)
solo-consultazione
Archived
2026-11-02T22:32:51.318Z
SHA-256 of the archived text
e9e165e3d1b80e010603ce67b548022da91cc35af29a59fdccdc2c46d184771a
Stable URL of this page
https://metraipolis.com/documento/dc_867fce42446e

How to cite

The Emerging Role of Glucagon-like Peptide 1 (GLP-1)-Based Medications in the Treatment of Heart Failure, with a Focus on Heart Failure with Preserved or… — Europe PMC PMID:42195123 — Europe PMC (en), https://europepmc.org/article/MED/42195123 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_867fce42446e (Metraipolis archive dc_867fce42446e, sha256 e9e165e3d1b80e010603ce67b548022da91cc35af29a59fdccdc2c46d184771a)
BibTeX
@misc{dc867fce42446e,
  title = {The Emerging Role of Glucagon-like Peptide 1 (GLP-1)-Based Medications in the Treatment of Heart Failure, with a Focus on Heart Failure with Preserved or… — Europe PMC PMID:42195123},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42195123},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_867fce42446e; sha256 e9e165e3d1b80e010603ce67b548022da91cc35af29a59fdccdc2c46d184771a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42195123. Agents can read the archived copy with the MCP tool read_document.